Showing results (111-120 of 1,014) with videos related to
Sort By:
Pageof 102
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.BMJ (Clinical Research Ed.)|March 5, 2008
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyLesley Wood, Matthias Egger, Lise Lotte Gluud, et al.Journal of Clinical Epidemiology|August 15, 2015
CONSORT extension for reporting N-of-1 trials (CENT) 2015 StatementSunita Vohra, Larissa Shamseer, Margaret Sampson, et al.Systematic Reviews|June 21, 2017
Identifying approaches for assessing methodological and reporting quality of systematic reviews: a descriptive studyKusala Pussegoda, Lucy Turner, Chantelle Garritty, et al.Annals of Internal Medicine|January 9, 2013
SPIRIT 2013 statement: defining standard protocol items for clinical trialsAn-Wen Chan, Jennifer M Tetzlaff, Douglas G Altman, et al.Systematic Reviews|July 20, 2017
Systematic review adherence to methodological or reporting qualityKusala Pussegoda, Lucy Turner, Chantelle Garritty, et al.Statistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-overFrançois Curtin, Diana Elbourne, Douglas G AltmanAnnals of Internal Medicine|January 16, 2002
Reporting on statistical methods to adjust for confounding: a cross-sectional surveyMarcus Müllner, Hugh Matthews, Douglas G AltmanTrials|October 11, 2012
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approachStephen Wright, Paul Duncombe, Douglas G AltmanStatistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomesFrançois Curtin, Diana Elbourne, Douglas G AltmanPageof 102